Patent details

Basic Information

Publication number:

EP2737927

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141564963

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ImidazoÖ1,2aÜpyrazines and compositions comprising them for the treatment of parasitic diseases

French Title of Invention:

ImidazoÖ1,2aÜpyrazines et compositions les contenan pour le traitement des maladies parasitaires

German Title of Invention:

ImidazoÖ1,2aÜpyrazine und Zusammensetzungen diese enthaltend zur Behandlung parasitärer Erkrankungen

SPC Number:

Dates

Filing date:

09/07/2010

Grant date:

30/03/2016

EP Publication Date:

30/03/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

04/06/2014

EP B1 Publication Date:

30/03/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

09/07/2016

Expiration date:

09/07/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/07/2010

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

Chatterjee Arnab

Address:

United States (US)

2

Name:

Nagle Advait S.

Address:

United States (US)

3

Name:

Kuhen Kelli

Address:

United States (US)

4

Name:

Tully David C.

Address:

United States (US)

5

Name:

Wu Tao

Address:

United States (US)

Priority

Priority Number:

224433 P

Priority Date:

10/08/2000

Priority Country:

United States (US)

Classification

Main IPC Class:

A61P 33/06;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages